Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sodium chloride 0.9% neb liq 2.5ml unit dose ampoules
1202020L0AACCCC
|
Sodium chloride (Nasal) | Sodium chloride | Ear, Nose and Oropharynx | 32,813 |
|
Sodium chloride 600mg modified-release tablets
0902012L0AAAJAJ
|
Sodium chloride (Systemic) | Sodium chloride | Nutrition and Blood | 19,183 |
|
Slow Sodium 600mg tablets
0902012L0BBAAAJ
|
Slow Sodium | Sodium chloride | Nutrition and Blood | 9,411 |
|
Saline Steripoules nebuliser liquid 2.5ml unit dose ampoules
1202020L0BJABCC
|
Saline Steripoule (Galen) | Sodium chloride | Ear, Nose and Oropharynx | 8,622 |
|
Sodium chloride 0.9% solution for injection 10ml ampoules
0902021S0AAACAC
|
Sodium chloride (Parenteral) | Sodium chloride | Nutrition and Blood | 6,353 |
|
Saline 0.9% neb liq 2.5ml Steri-Neb unit dose ampoules
1202020L0BCAACC
|
Saline Steri-Neb | Sodium chloride | Ear, Nose and Oropharynx | 3,876 |
|
Sodium chloride 0.9% solution for injection 5ml ampoules
0902021S0AAABAB
|
Sodium chloride (Parenteral) | Sodium chloride | Nutrition and Blood | 2,722 |
|
Sodium chloride 5% eye ointment
1108010K0AACFCF
|
Sodium chloride (Eye) | Sodium chloride | Eye | 2,437 |
|
Sodium chloride 0.9% eye dps 0.5ml ud preservative free
1108010K0AAAYAY
|
Sodium chloride (Eye) | Sodium chloride | Eye | 1,758 |
|
Sodium chloride 1.46g/5ml (5mmol/ml) oral solution
0902012L0AADHDH
|
Sodium chloride (Systemic) | Sodium chloride | Nutrition and Blood | 1,302 |
|
Minims saline 0.9% eye drops 0.5ml unit dose
1108010K0BBAAAY
|
Minims sodium chloride | Sodium chloride | Eye | 900 |
|
Sodium chloride 292.5mg/5ml (1mmol/ml) oral solution
0902012L0AADDDD
|
Sodium chloride (Systemic) | Sodium chloride | Nutrition and Blood | 621 |
|
Sodium chloride 0.9% solution for injection 2ml ampoules
0902021S0AAAAAA
|
Sodium chloride (Parenteral) | Sodium chloride | Nutrition and Blood | 500 |
|
Sodium chloride 0.9% solution for injection 20ml ampoules
0902021S0AAADAD
|
Sodium chloride (Parenteral) | Sodium chloride | Nutrition and Blood | 460 |
|
SodiClor 292.5mg/5ml (1mmol/ml) oral solution
0902012L0BCABDD
|
SodiClor | Sodium chloride | Nutrition and Blood | 450 |
|
SodiClor 1.46g/5ml (5mmol/ml) oral solution
0902012L0BCADDH
|
SodiClor | Sodium chloride | Nutrition and Blood | 430 |
|
Sodium chloride 0.9% inj 5ml Mini-Plasco ampoules
0902021S0BFADAB
|
Mini-Plasco sodium chloride | Sodium chloride | Nutrition and Blood | 379 |
|
Sodium chloride 0.9% inj 10ml Mini-Plasco ampoules
0902021S0BFABAC
|
Mini-Plasco sodium chloride | Sodium chloride | Nutrition and Blood | 357 |
|
Sodium chloride 0.9% solution for injection 50ml vials
0902021S0AABEBE
|
Sodium chloride (Parenteral) | Sodium chloride | Nutrition and Blood | 166 |
|
Sodium chloride 1.5g/5ml (5.13mmol/ml) oral solution
0902012L0AADFDF
|
Sodium chloride (Systemic) | Sodium chloride | Nutrition and Blood | 127 |
|
Sodium chloride 0.9% infusion 500ml bags
0902021S0AAAYAY
|
Sodium chloride (Parenteral) | Sodium chloride | Nutrition and Blood | 79 |
|
Sodium chloride 0.9% infusion 1litre polyethylene bottles
0902021S0AAAXAX
|
Sodium chloride (Parenteral) | Sodium chloride | Nutrition and Blood | 70 |
|
Sodium chloride 0.9% infusion 1litre bags
0902021S0AAAZAZ
|
Sodium chloride (Parenteral) | Sodium chloride | Nutrition and Blood | 65 |
|
Syrisal 292.5mg/5ml (1mmol/ml) oral solution
0902012L0BEAADD
|
Syrisal | Sodium chloride | Nutrition and Blood | 55 |
|
Sodium chloride 0.9% infusion 500ml polyethylene bottles
0902021S0AADQDQ
|
Sodium chloride (Parenteral) | Sodium chloride | Nutrition and Blood | 45 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.